FDA clears LTZ's IND application for second asset, LTZ-232, to treat patients with advanced metastatic colorectal cancer and other solid tumors.
Perrigo, the maker of all store brand formula in the U.S., announced it has been named "Baby Formula Maker of the Year" in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results